Skip to content
Subscriber Only

Race for Virus Cure Hits Reality as Complications Mount

  • Fast-moving studies hit bumps often seen in other research
  • Pauses for Lilly, J&J candidates come amid intense scrutiny
Bloomberg business news
Covid Vaccine Trials Hit Setbacks in Race for a Breakthrough
Updated on

The sprint to find medical breakthroughs to contain Covid-19 stumbled this week, as a pair of pharmaceutical giants working to develop treatments and vaccines suffered setbacks in the clinic.

On Tuesday, Eli Lilly & Co. said that enrollment in a government-sponsored clinical trial of its antibody therapy had been paused out of safety concerns. That came less than 24 hours after Johnson & Johnson said research on its experimental vaccine was paused after a study volunteer fell ill.